Prognostic relevance of detection of ligands for vertebrate galactins and a Lewis(Y)-specific monoclonal antibody: A prospective study of bronchial carcinoma patients treated surgically

International Journal of Oncology

Volumn 9, Issue 5, 1996, Pages 893-900

  Kayser, Klaus ^a   Kaltner, Herbert ^b   Dong, Xin ^b   Knapp, Margarete ^a   Schmettow, Heike Katharina ^a   Vlasova, Ekaterina V ^c   Bovin, Nicolai V ^c   Gabius, Hans Joachim ^b  

^a Thoraxklinik ^*  (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

lectins; ligandohistochemistry; lung cancer; lymph nodes; natural antibodies; prognosis; TMN stage

Indexed keywords

BETA GALACTOSIDE; GALECTIN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; LECTIN BINDING; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029969856     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Battifora H, Sorensen HR, Mehta P, Ahn C, Niland J, Hage E, Pettijohn DE and Olsson L: Tumor-associated antigen 43-9F is of prognostic value in squamous cell carcinoma of the lung. Cancer 70: 1867-1872, 1992.
2. b antigens with survival in patients with carcinoma of the lung. N Engl J Med 327: 14-18, 1992.
3. Lee JS, Ro JY, Sahise AA, Hong WK, Brown BW, Mountain CF and Hittelman WN: Expression of blood group antigen A: a favorable prognostic factor in non-small cell lung cancer. N Engl J Med 324: 1084-1090, 1992.
4. Kawai T, Suzuki M and Kase K: Expression of carbohydrate antigens in human pulmonary adenocarcinomas. Cancer 72: 1581-1587, 1993.
5. Ogawa J, Sano A, Inoue H and Koide S: Expression of Lewis-related antigen and prognosis in stage I non-small cell lung cancer. Ann Thorac Surg 59: 412-415, 1995.
6. Gabius H-J: Tumor lectinology: at the intersection of carbohydrate chemistry, biochemistry, cell biology, and oncology. Angew Chem Int Ed Engl 27: 1267-1276, 1988.
7. Gabius S, Joshi SS, Kayser K and Gabius H-J: The galactoside-specific lectin from mistletoe as biological response modifier. Int J Oncol 1: 705-708, 1992.
8. Gabius H-J and Gabius S (eds.): Lectins and Glycobiology. Springer Verlag, Heidelberg, 1993.
9. Gabius H-J and Gabius S (eds.): Glycosciences: Status and Perspectives. Chapman & Hall, Weinheim, London (In press).
10. Gabius H-J, Kayser K and Gabius S: Protein-Zucker-Erkennung. Grundlagen und medizinische Anwendung am Beispiel der Tumorlektinologie. Naturwissenschaften 82: 533-543, 1995.
11. Kayser K, Bovin NV, Korchagina EY, Zeilinger C, Zeng FY and Gabius H-J: Correlation of expression of binding sites for synthetic blood group A-, B-, and H- trisaccharides and for sarcolectin with survival of patients with bronchial carcinoma. Eur J Cancer 30A: 653-657, 1994.
12. Kayser K, Bovin NV, Zeng FY, Zeilinger C and Gabius H-J: Binding capacities to blood group antigen A, B, and H, DNA-and MST-measurements, and survival in bronchial carcinoma. Radiol Oncol 28: 282-286, 1994.
13. Gabius H-J: Detection and functions of mammalian lectins: with emphasis on membrane lectins. Biochim Biophys Acta 1074: 1-18, 1991.
14. Bovin NV and Gabius H-J: Polymer-immobilized carbohydrate ligands: versatile chemical tools for biochemistry and medical sciences. Chem Soc Rev 24: 413-421, 1995.
15. Danguy A, Kayser K, Bovin NV and Gabius H-J: The relevance of neoglycoconjugates for histology and pathology. Trends Glycosci Glycotechnol 7: 261-275, 1995.
16. Kabat EA, Liao J, Shyong J and Osserman EF: A monoclonal IgM1 macroglobulin with specificity for lacto-N-tetraose in a patient with bronchogenic carcinoma. J Immunol 126: 540-544, 1982.
17. Spiessl B, Beahrs OH, Hermanek P, Hutter RVP, Scheibe O, Sobin LH and Wagner G: TNM-Atlas, illustrierter Leitfaden zur TNM/pTNM-Klassifikation maligner Tumoren. Springer Verlag, Berlin, 1990.
18. Kayser K, Toomes H, Vollhaber HH and Burkhardt HU: Tumor volume and macroscopic growth pattern of bronchogenic carcinoma. Virchows Arch (A) 405: 387-397, 1985.
19. World Health Organisation (WHO) Histological classification of lung tumors. WHO, Geneva, 1981.
20. Gabius H-J: Influence of type of linkage and spacer on the interaction of β-galactoside-binding proteins with immobilized affinity ligands. Anal Biochcm 189: 91-94, 1990.
21. Gabius H-J, Wosgien B, Hendrys M and Bardosi A: Lectin localization in human nerve by biochemically defined lectin-binding glycoproteins, neoglycoprotein and lectin-specific antibody. Histochemistry 95: 269-277, 1991.
22. Kayser K, Gabius H-J, Rahn W, Martin H and Hagemeyer O: Variations of binding of labelled tumor necrosis factor α, epidermal growth factor, ganglioside GM-1 and N-acetylglucosamine, galactoside-specific mistletoe lectin and lectin-specific antibodies in mesothelioma and metastatic adenocarcinoma of the pleura. Lung Cancer 8: 185-192, 1992.
23. Schneller M, André S, Cihak J, Kaltner H, Merkle H, Rademaker GJ, Haverkamp J, Thomas-Oates J, Lösch U and Gabius H-J: Differential binding of two chicken β-galactoside-specific lectins to homologous lymphocyte subpopulations, and evidence for inhibitory activity of the dimeric lectin on stimulated T cells. Cell Immunol 166: 35-43, 1995.
24. Dong X, Amselgruber W, Kaltner H, Gabius H-J and Sinowatz F: Affinity-purified antibodies against α-galactosyl residues from human serum: comparison of their binding in bovine testicular tissue with that of the Griffonia simplicifolia lectin (GSI-B4) and impact of labeling on epitope localization. Eur J Cell Biol 68: 96-101, 1995.
25. Timoshenko AV, Kayser K, Drings P, André S, Dong X, Kaltner H, Schneller M and Gabius H-J: Carbohydrate-binding proteins (plant/human lectins and autoantibodies from human serum) as mediators of release of lysozyme, elastase, and myeloperoxidase. Res Exp Med 195: 169-174, 1995.
26. y. Hybridoma 13: 295-301, 1994.
27. Kaplan EL and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 447-454, 1958.
28. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170, 1966.
29. Bülzebruck H, Drings P, Kayser K, Schulz V, Tuengerthal S and Vogt-Moykopf I: Classification of lung cancer: first experiences with the new TNM classification (4th edition). Eur Respir J 4: 1197-1206, 1991.
30. Kayser K: Analytical Lung Pathology. Springer Verlag, Heidelberg, 1992.
31. Kayser K, Bülzebruck H, Merkle NM and Vogt-Moykopf I: Survival of operated bronchus carcinoma patients: a prospective study. J Surg Oncol 36: 84-92, 1987.
32. Kayser K, Bülzebruck H, Probst G and Vogt-Moykopf I: Retrospective and prospective tumor staging evaluating prognostic factors in operated bronchus carcinoma patients. Cancer 59: 355-361, 1987.
33. Martini N and Flehinge B: The role of surgery in N2 lung cancer. Surg Clin North Am 67: 1037-1049, 1987.
34. Ichinose I, Hara N, Ohta M, Yano T, Maeda K and Asoh H: Survival of patients with non-small cell lung cancer undergoing incomplete resection or exploratory thoracotomy with no resection. Lung Cancer 8: 265-274, 1993.
35. Yashar J and Yashar JJ: Factors affecting long-term survival of patients with bronchial carcinoma. Am J Surg 129: 386-393, 1975.
36. 1). Prognostic factors, results and recurrence. Chirurgia 6: 791-798, 1993.
37. Mountain CF: Surgery for stage IIIA-N2 non-small cell lung cancer. Cancer 73: 2589-2598, 1994.
38. Kayser K, Bülzebruck, H, Ebert W, Merkle NM and Vogt-Moykopf I: Local tumor inflammation, lymph node metastasis, and survival of operated bronchus carcinoma patients. J Natl Cancer Inst 77: 77-81, 1986.
39. Solís D, Romero A, Kaltner H, Gabius H-J and Diaz-Mauriño T: Different architecture of the combining site of the two chicken galectins revealed by chemical-mapping studies with synthetic ligand derivatives. J Biol Chem 271: 12744-12748, 1996.
40. Sparrow CP, Leffler H and Barondes SH: Multiple soluble β-galactoside-binding lectins from human lung. J Biol Chem 262: 7383-7390, 1987.
41. Lee RT, Gabius H-J and Lee YC: Ligand-binding characteristics of the major mistletoe lectin. J Biol Chem 267: 23722-23727, 1992.
42. Gupta D, Kaltner H, Dong X, Gabius H-J and Brewer CF: Comparative cross-linking activities of lactose-specific plant and animal lectins and a natural lactose-binding immunoglobulin G fraction from human serum with asialofetuin. Glycobiology (In press).